Tag Archives: cardiovascular disease
July 2005 Br J Cardiol 2005;12:275-82
Should all diabetic patients receive aspirin? Results from recent trials
Nick Barwell, Gillian Marshall, Claire McDougall, Adrian JB Brady, Miles Fisher
| Full text
January 2005 Br J Cardiol 2005;12:37-44
Current insights and new opportunities for smoking cessation
Hayden McRobbie
| Full textSeptember 2004 Br J Cardiol 2004;11:379-86
Cocoa, flavanols and cardiovascular risk
Norman K Hollenberg, Harold Schmitz, Ian MacDonald, Neil Poulter
| Full textMarch 2004 Br J Cardiol 2004;11:138-43
Will prevention of type 2 diabetes reduce the future burden of cardiovascular disease? The evidence base today
ohn HB Scarpello
| Full textNovember 2003 Br J Cardiol 2003;10:484-88
What’s new in cardiovascular disease: report from the PCCS Annual Meeting and AGM
Dr Ola Soyinka
| Full textNovember 2003 Br J Cardiol 2003;10:414-5
PCCS: critical thinking for times ahead
Fran Sivers
| Full textMay 2003 Br J Cardiol 2003;10:230-4
A survey among UK general practitioners on attitudes to cardiovascular postgraduate education
Terry McCormack
| Full textMarch 2003 Br J Cardiol 2003;10:118-22
The role of homocysteine in the clinical assessment of cardiovascular risk
Jennifer Bexley
| Full textOctober 2002 Br J Cardiol 2002;9:524-30
Workload implications of implementing national guidelines for hypertension
Karen Rowland Yeo, Wilfred W Yeo
| Full textMay 2002 Br J Cardiol 2002;9:255-7
Garlic in cardiovascular disease – the last word?
James M Lawrence, John PD Reckless
| Full textFor healthcare professionals only
